Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts that cover Voyager Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $14.33, which forecasts a 384.12% increase in the stock price over the next year. The lowest target is $7 and the highest is $30.

Price Target: $14.33 (+384.12%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.00	$14.33	$12	$30
Change	+136.49%	+384.12%	+305.41%	+913.51%

* Price targets were last updated on Apr 8, 2025.

Analyst Ratings

The average analyst rating for Voyager Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	5	5	4	3	3	3
Buy	3	3	5	5	5	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	10	9	9	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+913.51%	Apr 8, 2025
Sumant Kulkarni Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $14 → $12	Strong Buy	Maintains	$14 → $12	+305.41%	Mar 13, 2025
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+913.51%	Mar 13, 2025
Yanan Zhu Wells Fargo	Wells Fargo	Buy Maintains $12 → $10	Buy	Maintains	$12 → $10	+237.84%	Mar 12, 2025
Yun Zhong Wedbush	Wedbush	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Mar 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

39.40M

Decreased by -50.76%

from 80.00M

Revenue Next Year

70.47M

Increased by 78.88%

from 39.40M

EPS This Year

-2.16

from -1.13

EPS Next Year

-1.71

from -2.16

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	171.13M	37.42M	40.91M	250.01M	80.00M	39.40M	70.47M	72.93M
Revenue Growth	63.93%	-78.14%	9.33%	511.16%	-68.00%	-50.76%	78.88%	3.50%
EPS	0.98	-1.89	-1.21	2.97	-1.13	-2.16	-1.71	-1.52
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	14	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	66.9M	168.0M	129.0M
Avg	39.4M	70.5M	72.9M
Low	9.3M	9.3M	9.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-16.3%	326.3%	83.0%
Avg	-50.8%	78.9%	3.5%
Low	-88.4%	-76.4%	-86.8%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-1.66	-0.41	-0.84
Avg	-2.16	-1.71	-1.52
Low	-2.89	-2.85	-2.04

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.